1. Home
  2. KBSX vs TSHA Comparison

KBSX vs TSHA Comparison

Compare KBSX & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

N/A

Current Price

$1.75

Market Cap

50.6M

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

N/A

Current Price

$4.76

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KBSX
TSHA
Founded
1976
2019
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
1.7B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
KBSX
TSHA
Price
$1.75
$4.76
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
24.5K
★ 2.8M
Earning Date
11-18-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 5.56
EPS
★ N/A
N/A
Revenue
N/A
★ $9,773,000.00
Revenue This Year
$18.93
N/A
Revenue Next Year
$13.80
$1,023.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 17.28
52 Week Low
$0.81
$3.69
52 Week High
$1.77
$7.30

Technical Indicators

Market Signals
Indicator
KBSX
TSHA
Relative Strength Index (RSI) 69.07 38.99
Support Level $1.11 $4.37
Resistance Level N/A $5.07
Average True Range (ATR) 0.17 0.24
MACD 0.05 0.01
Stochastic Oscillator 84.42 37.78

Price Performance

Historical Comparison
KBSX
TSHA

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: